Carl Wolf PhD, MS, F-ABFT

Dr. Carl E. Wolf II, PhD, MS, F-ABFT, received his BS in Chemistry from Gannon University, Erie, Pennsylvania, in 1986, where he received the CRC Press’ Outstanding Freshman Chemist Award. He received his MS in Criminal Justice, with a Forensic Science option from Virginia Commonwealth University (VCU) in 1994, and received his Ph.D. in Pathology, with a focus on Forensic Toxicology from the Medical College of Virginia Campus at VCU in 2005.

Since 1987, Dr. Wolf has been employed at Medical College of Virginia Hospitals in various roles in the Clinical and Forensic Toxicology Laboratories. He regularly consults and/or lectures on toxicology and drug testing issues, and provides expert testimony in the Commonwealth of Virginia and Pennsylvania, and the States of Nebraska, North Carolina, and West Virginia.

Dr. Wolf contributed to over 160 presentations and peer-reviewed publications. He is a full member of both the Society of Forensic Toxicologists and the International Association of Forensic Toxicologists. He is a Fellow of the American Board of Forensic Toxicologists (ABFT) and has been certified by ABFT since 2001. In 2007, he was a member of the group that received an Educational Innovation Award from the School of Medicine at the MCV campus of VCU for developing and maintaining an online CE program for chronic non-malignant pain management curriculum.

Dr. Wolf was awarded three grants from the National Institute of Justice (NIJ): (2017) studying the matrix effects that liver tissue has on the analysis of opiates, (2018), studying the stability of cannabinoids in marijuana infused edibles, and (2022) studying the ability to detect new cannabinoid analogs in urine. Dr. Wolf is a member of the Clinical and Laboratory Standards Institute, Inc. (CLSI) Expert Panel on Clinical Chemistry and Toxicology, Vice-Chairholder for the document development committee for Guideline C40: Measurement Procedures for the Determination of Lead Concentrations in Blood, and a member of the document development committee for Guideline C38: Control of Preanalytical Variation in Trace Element Determinations.